Status:
COMPLETED
Observational Retrospective Study of Effectivity and Tolerability in Patients With Lacosamide Medication
Lead Sponsor:
Instituto de Investigacion Sanitaria La Fe
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Brief Summary
Lacosamide is an antiepileptic drug approved for using like adjuvant treatment in adults epileptic crisis. Previous studies has granted to the adjuvant therapy a significant efficacy. This is an obse...
Detailed Description
During the treatment we will performed a analysis in three different times (3, 6 and 12 month)for obtain a vision of tolerability and efficacy for Lacosamide in usual clinical practice. We intended de...
Eligibility Criteria
Inclusion
- The patient, male or female, over 18 years.
- The patient has a diagnosis of prostate cancer of any kind, and has been treated with Lacosamide according to routine clinical practice.
- The patient had at least one Partial Crisis during the year prior to initiation of treatment with Lacosamide.
- The patient or their legal representative is reliable and able to adhere to the protocol (ie, is able to understand and complete the interview at the study visit), at the discretion of the investigator.
Exclusion
- Patient is participating in another study of a medicinal product research (PMI) or a medical implant.
- Patients with other types of epilepsy.
- Patients with a history of chronic alcoholism or drug abuse in the last year.
- Patients who are not in possession of his faculties at the time of obtaining the Informed Consent.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
860 Patients enrolled
Trial Details
Trial ID
NCT01858870
Start Date
April 1 2012
End Date
December 1 2012
Last Update
May 21 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iis la Fe
Valencia, Valencia, Spain, 46026